Search Results
Found 1 results
510(k) Data Aggregation
(40 days)
Cardinal Health DuraBlue™ Sterilization Wrap is intended to enclose another medical device that is to be sterilized by a health care provider by the following modality:
- Standard and Advanced cycles of the STERRAD® NX Sterilization System .
The wrap is intended to allow sterilization of the enclosed medical device(s) and to maintain sterility of the enclosed device(s). Maintenance of package sterility was validated with real-time testing for the following durations: - 30 days following sterilization by STERRAD® NX (Standard and Advanced cycles) .
All models of DuraBlue™ Sterilization Wrap have been validated for use with the following STERRAD® NX Sterilization Cycles.
Cardinal Health DuraBlue™ Sterilization Wraps are double layer sterilization wraps made from 100% polypropylene spunbond-meltblown-spunbond (SMS) fabric. They are intended to be used to enclose another medical device that is to be sterilized by a health care provider by Standard and Advanced cycles of the STERRAD® NX hydrogen peroxide gas plasma sterilization system. This wrap design allows for use of the simultaneous double-wrapping technique and also allows for a sterilized pack to be opened aseptically.
This submission covers six different models of Cardinal Health DuraBlue™ Sterilization Wrap. Each model is made from material of a different basis weight, though all models utilize the same material technology.
The provided document describes the Cardinal Health DuraBlue™ Sterilization Wrap, its intended use, and the studies conducted to demonstrate its performance and substantial equivalence to predicate devices. However, it does not contain the level of detail typically found in a clinical study report for an AI/ML medical device, which would include specific acceptance criteria with numerical targets and the reported device performance against those targets.
Instead, the document focuses on regulatory approval for the sterilization wrap itself, demonstrating its ability to facilitate sterilization and maintain sterility. The "acceptance criteria" here are implied by the successful completion of various performance tests in accordance with FDA guidance for sterilization packaging systems.
Here's an attempt to structure the information based on your request, with noted limitations due to the nature of the source document:
1. Table of Acceptance Criteria and Reported Device Performance
Given that this is a sterilization wrap, the "acceptance criteria" are not reported as numerical metrics like sensitivity or specificity (as would be for an AI diagnostic device). Instead, they are functional requirements for a sterilization packaging system. The performance is reported as successful completion of these requirements.
| Acceptance Criteria (Implied from FDA Guidance) | Reported Device Performance |
|---|---|
| Sterilization Efficacy: The wrap must allow for effective sterilization of enclosed contents. | "Successful completion of the sterilization performance tests demonstrated that the wrap both allows for sterilization of the enclosed contents..." The DuraBlue™ Sterilization Wrap was validated for use with Standard and Advanced cycles of the STERRAD® NX Sterilization System for specific load types (e.g., up to 10 lumens of specified dimensions, or a flexible endoscope). |
| Maintenance of Package Sterility: The wrap must maintain sterility of enclosed devices for a specified duration. | "...and also maintains sterility of the enclosed devices until opened within the period of time for which performance data demonstrating maintenance of sterility has been provided." Maintenance of package sterility was validated with real-time testing for 30 days following sterilization by STERRAD® NX (Standard and Advanced cycles). |
| Physical Properties: The wrap must retain its physical integrity and properties after sterilization. | "The physical properties of all wrap models have been characterized both before and after exposure to STERRAD® NX sterilization. The resulting data supports the conclusion that Cardinal Health DuraBlue™ Sterilization Wrap sterilized with the STERRAD® NX Standard or Advanced cycles is substantially equivalent to Cardinal Health DuraBlue™ Sterilization Wrap sterilized with the STERRAD® 100S system. The data demonstrates that the DuraBlue™ Sterilization Wrap is compatible with the Standard and Advanced cycles of the STERRAD® NX Sterilization System." |
| Biocompatibility: The materials must be biocompatible. | "Biocompatibility in compliance with the methods of ISO 10993." (No specific results provided, but stated as completed). |
| Substantial Equivalence: Demonstrated equivalence to predicate devices. | The device was found substantially equivalent to predicate devices (K112283 and K120658), having the same intended use, material composition, physical and chemical properties, configurations/dimensions, and demonstating maintenance of package sterility. This was confirmed by the FDA's 510(k) clearance (K122507). |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: The document mentions "Extensive performance testing" and "Sterility Maintenance Validation Study" and "performance tests." However, it does not specify a numerical sample size (e.g., number of wraps, number of test cycles, or number of individual tests) for these studies. It lists various load configurations for the six different wrap models (CH100-CH600) used in the Sterility Maintenance Validation Study, each with a 23 in. x 11 in. x 4 in. tray containing metal instruments.
- Data Provenance: The document does not explicitly state the country of origin. Given the manufacturer (Cardinal Health, located in McGraw Park, IL, USA) and the FDA 510(k) submission, it is highly likely that the studies were conducted in the USA. The studies appear to be prospective in nature, as they involve testing the device under specific conditions set up to validate its performance for sterilization and sterility maintenance.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
This information is not applicable and therefore not provided in the document. The DuraBlue™ Sterilization Wrap is a sterile barrier system, not a diagnostic or AI device that requires expert ground truth for image interpretation or disease diagnosis. The "ground truth" for its performance is established through microbiological testing (sterilization efficacy and sterility maintenance) and physical material testing, rather than expert consensus on observational data.
4. Adjudication Method for the Test Set
This information is not applicable and therefore not provided in the document. Adjudication methods (like 2+1, 3+1) are used in studies involving human interpretation or subjective assessments, typically for AI/ML devices where differences in expert opinions need to be reconciled to establish a robust ground truth. For this device, the outcomes are objective (e.g., presence/absence of microbial growth, material tear strength, seal integrity).
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
This information is not applicable and therefore not provided in the document. MRMC studies are designed to evaluate the performance of diagnostic tools when used by multiple readers across multiple cases, often comparing AI-assisted performance to unassisted human performance. The DuraBlue™ Sterilization Wrap is a medical device used for packaging, not for diagnostic interpretation, so such a study would not be relevant.
6. Standalone Performance Study (Algorithm Only)
This information is not applicable and therefore not provided in the document. The DuraBlue™ Sterilization Wrap is a physical product, not an algorithm or software. Its performance is inherent to its physical and material properties and how it interacts with the sterilization process, not an independent algorithm.
7. Type of Ground Truth Used
The "ground truth" for the performance of the DuraBlue™ Sterilization Wrap is established through objective laboratory testing:
- Microbiological assays: To confirm sterilization efficacy (e.g., kill rate of biological indicators) and maintenance of sterility (e.g., absence of microbial ingress after a specified period).
- Physical and chemical property testing: To assess material integrity, strength, porosity, and compatibility with the sterilization process (e.g., tensile strength, burst strength, visual inspection for damage, chemical compatibility with hydrogen peroxide plasma).
8. Sample Size for the Training Set
This information is not applicable and therefore not provided in the document. The DuraBlue™ Sterilization Wrap is a physical product and does not use machine learning algorithms that require a "training set" of data.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable and therefore not provided in the document, as there is no "training set" for this type of medical device.
Ask a specific question about this device
Page 1 of 1